CKDXF
Price:
$0.01
Market Cap:
$12.38M
Ceryvyn Therapeutics Ltd is a clinical-stage biopharmaceutical company developing therapies for the rare lung disease lymphangioleiomyomatosis (LAM). Its lead program, CYV-101, is a fusion protein designed to neutralize VEGF-C and VEGF-D, key signaling proteins involved in the disease. The company was formerly known as Opthea Limited.
Industry
Biotechnology
IPO Date
2011-10-25
Stock Exchange
OTC
Ticker
CKDXF
According to Ceryvyn Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is -9751093.73. This represents a change of -101.82% compared to the average of 537.23M of the last 4 quarters.
The mean historical Enterprise Value of Ceryvyn Therapeutics Limited over the last ten years is 303.18M. The current -9751093.73 Enterprise Value has changed -421.62% with respect to the historical average. Over the past ten years (40 quarters), CKDXF's Enterprise Value was at its highest in in the December 2024 quarter at 1.01B. The Enterprise Value was at its lowest in in the December 2014 quarter at -9002416.46.
Average
303.18M
Median
199.73M
Minimum
70.25M
Maximum
1.06B
Discovering the peaks and valleys of Ceryvyn Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 896.88%
Maximum Annual Enterprise Value = 1.06B
Minimum Annual Increase = -46.10%
Minimum Annual Enterprise Value = 70.25M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.06B | 461.51% |
| 2024 | 189.36M | -9.88% |
| 2023 | 210.11M | -39.16% |
| 2022 | 345.33M | 15.82% |
| 2021 | 298.17M | -46.10% |
| 2020 | 553.15M | 340.77% |
| 2019 | 125.50M | 40.41% |
| 2018 | 89.38M | 2.37% |
| 2017 | 87.31M | 24.28% |
| 2016 | 70.25M | 896.88% |
The current Enterprise Value of Ceryvyn Therapeutics Limited (CKDXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
487.58M
5-year avg
421.25M
10-year avg
303.18M
Ceryvyn Therapeutics Limited’s Enterprise Value is less than Claritas Pharmaceuticals, Inc. (923.66K), less than Inventiva S.A. (490.37M), less than Oxurion N.V. (11.21M), less than Columbia Care Inc. (808.77M), less than TerrAscend Corp. (362.24M), less than Kindstar Globalgene Technology, Inc. (866.19M), less than SS Innovations International, Inc. (768.35M), less than Adcock Ingram Holdings Limited (11.12B), less than AnGes, Inc. (18.45B), less than Dong Fang Hui Le Inc. (400.40M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 923.66K | $3.66K | |
| 490.37M | $499.23M | |
| 11.21M | $433.72M | |
| 808.77M | $521.35M | |
| 362.24M | $601.91M | |
| 866.19M | $675.13M | |
| 768.35M | $770.51M | |
| 11.12B | $624.32M | |
| 18.45B | $142.50M | |
| 400.40M | $400.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ceryvyn Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ceryvyn Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ceryvyn Therapeutics Limited's Enterprise Value?
What is the highest Enterprise Value for Ceryvyn Therapeutics Limited (CKDXF)?
What is the 3-year average Enterprise Value for Ceryvyn Therapeutics Limited (CKDXF)?
What is the 5-year average Enterprise Value for Ceryvyn Therapeutics Limited (CKDXF)?
How does the current Enterprise Value for Ceryvyn Therapeutics Limited (CKDXF) compare to its historical average?